Chargement en cours...
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
Enregistré dans:
| Publié dans: | Indian J Dermatol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://ncbi.nlm.nih.gov/pubmed/26538739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.164447 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|